EN DE
Watch Reliance Chemotex Industries Limited for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Reliance Chemotex Industries Limited (RELCHEMQ) fair value: what the stock is really worth

As of Nov 16, 2026: fair value (intrinsic value) of Reliance Chemotex Industries Limited stock ₹126, price ₹119, upside +6.6%, quality 37 out of 100. Rating: fairly valued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Cyclical IN · ISIN INE750D01016

RC Reliance Chemotex Industries Limited logo Broad data Nov 13, 2026

Reliance Chemotex Industries Limited

RELCHEMQ · NSE

The stock is already about fairly priced, weak company and falling price: meets none of the 3 rules.

Get notified free when this changes
Broad data 
Profit last quarter +28% vs. a year ago. 
Fair value ₹126.46 · Fairly valued 
Expensive Growth (revenue 5y +7.6 %/yr in INR) 
Thin margins · 1.5% net margin (TTM) 
Moderate debt 
0.4% dividend yield · Token dividend
Mixed vs. peers (6/13) 
Quality 37/100 
Falling price (downtrend) 
Negative free cash flow 
Narrow moat 28/100
Watch Reliance Chemotex Industries Limited for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹317.58 ₹104.72 Fair Value ₹126.46 May 2022 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 13, 2026.

How to read this chart

54‑month range ₹104.72 – ₹317.58 · fair‑value band ₹117.42 – ₹188.74 · the ₹118.64 price screens below the ₹126.46 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 13, 2026.

Follow Reliance Chemotex Industries in your weekly email

Every Wednesday you see whether Reliance Chemotex Industries is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Reliance Chemotex Industries Limited engages in the manufacture and sale of synthetic and blended yarns in India. The company offers home furnishing, industrial, and apparel yarns. It also exports its products.

Show moreShow less

Reliance Chemotex Industries Limited was incorporated in 1977 and is based in Mumbai, India.

Stock analysis

Reliance Chemotex Industries Limited (RELCHEMQ) currently trades at ₹118.64, while our model-based Fair Value estimate is ₹126.46, so the stock looks roughly fairly valued today (gap 6.2%).

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of ₹258.41 per share, and 8 of the 16 models we run sit above the ₹118.64 price.

Bear case: the Earnings-Based group reads lowest at ₹73.26, and 8 of the 16 models stay below the price. Data coverage for this calculation is high.

Scenario range: ₹117.42 (bear) to ₹188.74 (bull), the price of ₹118.64 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 37/100 (below-average quality), in the Consumer Cyclical sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Reliance Chemotex Industries Limited reported revenue of ₹3.6B in FY2026 versus ₹3.5B in FY2022, a compound +1.0%/yr. Reported net income was ₹52.6M in FY2026, compounding −26.6%/yr from FY2022.

Key figures

Market cap ₹896M (≈ $9.5M) Micro · P/E ratio 16.1 · P/S ratio 0.24 · EPS (TTM) ₹7.37 · Dividend yield 0.4% · Net margin 1.5% · Return on equity 3.8% · Return on assets (EBIT) 5.5% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (medium confidence).

What moves the price

The share trades about 21% below its 52-week high and 13% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Cyclical peers we cover trades at −14% fair-value upside, at 7%, RELCHEMQ screens cheaper than that median.

Fair Value models

Bear ₹117.42 Fair Value ₹126.46 Bull ₹188.74
Price ₹118.64 · Upside +6.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 8 months old). Earnings retained since then (₹4.35 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Owner Earnings ₹156.41 ₹258.41 ₹377.17 76
Residual Income ₹117.42 ₹120.01 ₹126.98 76
EPV ₹46.14 ₹73.26 ₹95.32 72
All 16 models by family
DCF Models
Owner Earnings ₹156.41 ₹258.41 ₹377.17 76
Earnings-Based
Graham-Dodd ₹47.43 ₹112.12 ₹144.41 65
PEG = 1.0 ₹25.96 ₹37.09 ₹48.22 57
EPV ₹46.14 ₹73.26 ₹95.32 72
Dividend Discount
Gordon GGM ₹3.52 ₹5.26 ₹6.84 69
DDM Multi-Stage ₹3.52 ₹4.79 ₹5.92 67
Multiples
P/E Multiple ₹115.08 ₹153.45 ₹191.81 63
P/S Multiple ₹88.93 ₹118.57 ₹148.21 58
P/B Multiple ₹566.22 ₹754.97 ₹943.71 55
EV/EBIT ₹126.09 ₹280.69 ₹435.29 62
EV/EBITDA ₹147.98 ₹309.87 ₹471.76 64
EV/Revenue n/a ₹108.91 ₹242.90 50
Asset-Based
NCAV (Graham) ₹94.37 ₹126.46 ₹188.74 54
Economic Profit
Residual Income ₹117.42 ₹120.01 ₹126.98 76
ROIC Compounder ₹46.14 ₹73.26 ₹95.32 71
Growth Earnings
Growth-Adj P/E ₹86.97 ₹124.25 ₹161.52 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 37/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 28
How much profit the company makes from its sales and capital
Quality Growth 28
Are margins and returns getting better?
Cashflow 13
Do the profits arrive as real cash?
Financial strength 13
Debt, balance sheet and risk of trouble
Investment 81
Does it invest with discipline instead of growing at any price?
Low Volatility 73
How calm the share price moves, does not count
Price momentum 28
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 18
Distance to the 52-week high, does not count
New shares 73
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 43/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+1.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.6%
Start year 2021 (pandemic). Over 10 years: +3.5% a year
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.7%
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−13.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year−13.8%
Dividend (yield on the price)0.4%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−13.8% vs −7.1%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.6% → 7%
Pace: the 5-year rate starts in 2021 (pandemic)
⚠ Revenue per share shrinking 1.8%/yr over ~10Y (margins intact) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.

Watch RELCHEMQ, get fair value alerts →

Compare Reliance Chemotex Industries Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Textile Manufacturing · 345 stocks

Beats the industry median on 6/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 37 · Bottom 25%
Fair Value upside +6.6% · Above median
Profitability
Return on equity (12 months) 3.8% · Below median
Return on assets 1.0% · Below median
Net margin (12 months) 1.5% · Below median
Operating margin (12 months) 7.3% · Above median
Growth and dividend
Revenue growth (quarter YoY) 7.0% · Below median
Dividend yield (12 months) 0.4% · Bottom 25%
Balance sheet
Debt / equity 1.03× · Highest 25%

Valuation Multiplesvs Textile Manufacturing median · lower = cheaper

P/E (12 months) 16.1× · Cheaper than median
P/B 0.63× · Cheaper than median
P/S (12 months) 0.24× · Cheapest 25%
EV/EBITDA 5.4× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)42 · sector 10
FUTURE (revenue growth)35 · sector 38
PAST (return on equity)15 · sector 19
HEALTH (low debt)49 · sector 95
DIVIDEND (yield)8 · sector 38

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Textile Manufacturing stocks, each showing price versus our Fair Value estimate.

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Reliance Chemotex Industries Limited: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Reliance Chemotex Industries Limited Fair Value". https://www.fairvalue-calculator.com/stock/RELCHEMQ

Frequently asked questions

Is Reliance Chemotex Industries Limited (RELCHEMQ) overvalued or undervalued?
As of Nov 13, 2026, our model estimates a fair value of ₹126.46 versus a price of ₹118.64, about +7% upside (fairly valued).
What is the fair value of RELCHEMQ?
Our model-based fair value for Reliance Chemotex Industries Limited is ₹126.46 (as of Nov 13, 2026), built from audited fundamentals. The current price: ₹118.64.
What is the quality score of RELCHEMQ?
Reliance Chemotex Industries Limited has a Quality Score of 37/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Reliance Chemotex Industries Limited (RELCHEMQ)?
Our model-based price target is the fair value of ₹126.46 (as of Nov 13, 2026) from 16 valuation models. Cautious scenario ₹117.42, optimistic scenario ₹188.74. It is a calculation from audited fundamentals, not an analyst target.
What is the Reliance Chemotex Industries Limited stock forecast for 2026?
Our models put fair value at ₹126.46, about +7% upside versus a price of ₹118.64 (fairly valued). Cautious scenario ₹117.42, optimistic scenario ₹188.74. The calculation is refreshed regularly with new filings.
What is the revenue of Reliance Chemotex Industries Limited (RELCHEMQ)?
Reliance Chemotex Industries Limited reported trailing-twelve-month revenue of about ₹3.7B (latest available figure, as of Nov 13, 2026).
Does Reliance Chemotex Industries Limited pay a dividend?
Reliance Chemotex Industries Limited currently shows a dividend yield of 0.42% relative to its recent price (as of Nov 13, 2026).
How much is the dividend of Reliance Chemotex Industries Limited (RELCHEMQ) and when is the ex-dividend date?
Reliance Chemotex Industries Limited pays a dividend of ₹0.5 per share a year, a dividend yield of 0.4%. The last ex-dividend date was Sep 18, 2026. A dividend has been paid every year since at least 2022. The payout ratio is 6.8% of earnings. Our assessment: Token dividend. At a yield of 0.4% the dividend is symbolic. On paper it is not fully covered by earnings or free cash flow, but at this size that hardly matters: even scrapping it entirely would cost less than 0.4% a year, and coverage ratios on amounts this small swing with ordinary working-capital movements. Judge this company on its business, not on its dividend.
What is the intrinsic value of Reliance Chemotex Industries Limited (RELCHEMQ)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Reliance Chemotex Industries Limited it is ₹126.46 per share (as of Nov 13, 2026), against a price of ₹118.64. It is the blended result of 16 valuation models in 7 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Reliance Chemotex Industries Limited stock overvalued or undervalued in 2026?
As of Nov 13, 2026, RELCHEMQ trades below its calculated fair value: price ₹118.64, fair value ₹126.46, a gap of about +7% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of RELCHEMQ?
No. The price is what the market pays today (₹118.64); the fair value is what the company's own numbers justify (₹126.46). For Reliance Chemotex Industries Limited the two are ₹7.82 per share apart. That gap is exactly why we show both numbers side by side.
How much is Reliance Chemotex Industries Limited worth?
The market values Reliance Chemotex Industries Limited at about ₹896M (market capitalisation, as of Nov 13, 2026). Per share that is ₹118.64; our models calculate a fair value of ₹126.46 per share.
What do the bullish and bearish scenarios say about RELCHEMQ?
Our models span a range for Reliance Chemotex Industries Limited: cautious scenario ₹117.42, base ₹126.46, optimistic ₹188.74 per share (as of Nov 13, 2026, price ₹118.64). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of RELCHEMQ?
Reliance Chemotex Industries Limited trades at a price-to-earnings ratio of 16.1 (as of Nov 13, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹126.46 is built from several models across several years. Other multiples: P/B 0.6, P/S 0.2, EV/EBITDA 5.4.
How solid is the balance sheet of Reliance Chemotex Industries Limited (RELCHEMQ)?
Balance-sheet figures for Reliance Chemotex Industries Limited (as of Nov 13, 2026): return on equity 3.8%, debt of 1.03 per unit of equity. They feed the Quality Score of 37/100, which measures business quality independently of the share price.
How far is RELCHEMQ from its 52-week high?
Reliance Chemotex Industries Limited trades at ₹118.64, about 21% below its 52-week high of ₹150.95 and 13% above the low of ₹104.72 (as of Nov 16, 2026). Distance from the high says nothing about value: that is what the fair value of ₹126.46 is for.
Which stocks are comparable to Reliance Chemotex Industries Limited?
From the same area (Consumer Cyclical) we also value Tongkun Group, Inner Mongolia ERDOS Resources Co, Far Eastern New Century Corporation, K.P.R. Mill Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Reliance Chemotex Industries Limited stock attractive at the current price?
The data as of Nov 13, 2026: price ₹118.64, calculated fair value ₹126.46 (+7%), Quality Score 37/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of RELCHEMQ calculated?
We run Reliance Chemotex Industries Limited through 16 models from 7 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ₹126.46 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.6% above its aggregate fair value. Reliance Chemotex Industries Limited currently trades 6% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Reliance Chemotex Industries Limited (RELCHEMQ)?
The closing price on Nov 16, 2026 was ₹118.64. Our model-based fair value is ₹126.46, about +7% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Reliance Chemotex Industries Limited right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The price sits in the lower half of our model range, the side with the larger margin of safety. The data supports the verdict: every model runs on fully documented inputs.
Where does the earnings growth of Reliance Chemotex Industries Limited (RELCHEMQ) come from?
Earnings per share at Reliance Chemotex Industries Limited fell 8.0 % a year from 2015 to 2026. Broken into its drivers: revenue per share −1.8 %, EBIT margin +9.5 %, tax rate +0.5 %, residual (interest, one-offs) −14.9 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Reliance Chemotex Industries Limited

How large is the market capitalisation of Reliance Chemotex Industries Limited (RELCHEMQ)?
The market capitalisation of Reliance Chemotex Industries Limited is ₹896M (≈ $9.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Reliance Chemotex Industries Limited (RELCHEMQ)?
The price-to-sales ratio of Reliance Chemotex Industries Limited is 0.24 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Reliance Chemotex Industries Limited (RELCHEMQ)?
Earnings per share at Reliance Chemotex Industries Limited are ₹7.37 (price ÷ EPS = P/E 16.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Reliance Chemotex Industries Limited (RELCHEMQ)?
The dividend yield of Reliance Chemotex Industries Limited is 0.4% (payout 6.8%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Reliance Chemotex Industries Limited (RELCHEMQ)?
The net margin of Reliance Chemotex Industries Limited is 1.5% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Reliance Chemotex Industries Limited (RELCHEMQ)?
The return on equity (ROE) of Reliance Chemotex Industries Limited is 3.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Reliance Chemotex Industries Limited (RELCHEMQ)?
On an EBIT basis the return on assets of Reliance Chemotex Industries Limited is 5.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Reliance Chemotex Industries Limited (RELCHEMQ)?
The operating margin of Reliance Chemotex Industries Limited is 7.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Reliance Chemotex Industries Limited (RELCHEMQ)?
Revenue at Reliance Chemotex Industries Limited is growing 7.0% versus a year earlier (3y avg +0.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Reliance Chemotex Industries Limited (RELCHEMQ)?
Earnings per share at Reliance Chemotex Industries Limited are growing 28.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Reliance Chemotex Industries Limited (RELCHEMQ) generate?
The free cash flow of Reliance Chemotex Industries Limited is −₹28.0M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Reliance Chemotex Industries Limited (RELCHEMQ) carry?
The net debt of Reliance Chemotex Industries Limited is ₹2.5B (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Reliance Chemotex Industries Limited in the live analysis

One click puts Reliance Chemotex Industries Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.